^
Association details:
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Title:

Abstract CT138: Molecular markers in a phase I dose expansion study of PF-06801591 in locally advanced or metastatic non-small-cell lung cancer and urothelial carcinoma

Published date:
04/27/2020
Excerpt:
In UC, certain high baseline CD8 levels by IHC were associated with better ORR, PFS and OS.
DOI:
10.1158/1538-7445.AM2020-CT138
Trial ID: